Showing results (171-180 of 282) with videos related to
Sort By:
Pageof 29
Frontiers in Oncology|November 10, 2025
Oxphos targeting of MYCN-amplified neuroblastomaSoraya Epp, Donagh Egan, Evon Poon, et al.Bioscience Reports|February 4, 2015
Signalling mechanisms regulating phenotypic changes in breast cancer cellsNatalia Volinsky, Cormac J McCarthy, Alex von Kriegsheim, et al.Cancers|July 13, 2024
Cell State Transition Models Stratify Breast Cancer Cell Phenotypes and Reveal New Therapeutic TargetsOleksii S Rukhlenko, Hiroaki Imoto, Ayush Tambde, et al.Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 21, 2020
An Investigation into Proteomic Constituents of Cerebrospinal Fluid in Patients with Chronic Peripheral Neuropathic Pain Medicated with Opioids- a Pilot StudyJonathan Royds, Hilary Cassidy, Melissa J Conroy, et al.Journal of Neuroimmunology|May 4, 2020
Examination and characterisation of burst spinal cord stimulation on cerebrospinal fluid cellular and protein constituents in patient responders with chronic neuropathic pain - A Pilot StudyJonathan Royds, Melissa J Conroy, Margaret R Dunne, et al.Journal of Cell Science|February 14, 2012
ERK2 drives tumour cell migration in three-dimensional microenvironments by suppressing expression of Rab17 and liprin-β2Anne von Thun, Marc Birtwistle, Gabriela Kalna, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasisSuzanne Hagan, Fahd Al-Mulla, Elizabeth Mallon, et al.BMC Bioinformatics|December 8, 2016
Comparison of different statistical approaches for urinary peptide biomarker detection in the context of coronary artery diseaseEleanor Stanley, Eleni Ioanna Delatola, Esther Nkuipou-Kenfack, et al.RNA (New York, N.Y.)|February 28, 2014
Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma developmentAsaf Shilo, Vered Ben Hur, Polina Denichenko, et al.The Journal of Biological Chemistry|November 30, 2002
Differences on the inhibitory specificities of H-Ras, K-Ras, and N-Ras (N17) dominant negative mutants are related to their membrane microlocalizationDavid Matallanas, Imanol Arozarena, Maria T Berciano, et al.Pageof 29